Shares of Novavax plunged by 8%, compounding losses in the wake of ... Write to Rob Curran at [email protected] About Dow Jones Newswires Dow Jones Newswires is a market-moving financial and ...

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced ...

The deal is expected to close by the end of March, subject to shareholder and regulatory approvals. Write to Dean Seal at [email protected] About Dow Jones Newswires Dow Jones Newswires is a ...

Analyst Alec Stranahan of Bank of America Securities reiterated a Hold rating on Novavax (NVAX – Research Report), reducing the price ...